Bone Biologics Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 4.13 K | $4.54 K | 22.11% | 0.23% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 230 | $253 | 0.00% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 56 | $62 | -97.13% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bone Biologics Corp institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Bone Biologics Corp. The most heavily invested institutionals were:
Tower Research Capital LLC (TRC): 4,126
SBI Securities Co., Ltd.: 230
UBS Group AG: 56
DRW Securities, LLC: 0
CITADEL ADVISORS LLC: 0
TWO SIGMA INVESTMENTS, LP: 0
0.25% of Bone Biologics Corp stock is owned by institutional investors.
Institutional investors have bought a total of 4.55 K shares in the last 24 months. This purchase volume represents approximately $5.73 K in transactions.